| Prostate alpha/beta revisited–an analysis of clinical results from 14 168 patients A Dasu, I Toma-Dasu Acta Oncologica 51 (8), 963-974, 2012 | 257 | 2012 |
| Is the α/β value for prostate tumours low enough to be safely used in clinical trials? A Daşu Clinical Oncology 19 (5), 289-301, 2007 | 195 | 2007 |
| Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia A Daşu, I Toma-Daşu, M Karlsson Physics in Medicine & Biology 48 (17), 2829, 2003 | 170 | 2003 |
| The use of risk estimation models for the induction of secondary cancers following radiotherapy A Daşu, I Toma-Daşu, J Olofsson, M Karlsson Acta Oncologica 44 (4), 339-347, 2005 | 150 | 2005 |
| Dose prescription and treatment planning based on FMISO-PET hypoxia I Toma-Dasu, J Uhrdin, L Antonovic, A Dasu, S Nuyts, P Dirix, ... Acta Oncologica 51 (2), 222-230, 2012 | 121 | 2012 |
| Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis? JF Fowler, I Toma-Dasu, A Dasu Anticancer research 33 (3), 1009-1011, 2013 | 93 | 2013 |
| Inducible repair and the two forms of tumour hypoxia-time for a paradigm shift J Denekamp Acta Oncologica 38 (7), 903-918, 1999 | 93 | 1999 |
| New insights into factors influencing the clinically relevant oxygen enhancement ratio A Daşu, J Denekamp Radiotherapy and Oncology 46 (3), 269-277, 1998 | 84 | 1998 |
| Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy? J Denekamp, A Daşu, A Waites Advances in enzyme regulation 38 (1), 281-299, 1998 | 73 | 1998 |
| Quality control in cone-beam computed tomography (CBCT) EFOMP-ESTRO-IAEA protocol (summary report) H de Las Heras Gala, A Torresin, A Dasu, O Rampado, H Delis, IH Girón, ... Physica Medica 39, 67-72, 2017 | 72 | 2017 |
| Clinical oxygen enhancement ratio of tumors in carbon ion radiotherapy: the influence of local oxygenation changes L Antonovic, E Lindblom, A Dasu, N Bassler, Y Furusawa, I Toma-Dasu Journal of radiation research 55 (5), 902-911, 2014 | 72 | 2014 |
| Dose prescription and optimisation based on tumour hypoxia I Toma-Daşu, A Daşu, A Brahme Acta Oncologica 48 (8), 1181-1192, 2009 | 72 | 2009 |
| Impact of variable RBE on proton fractionation A Dasu, I Toma‐Dasu Medical physics 40 (1), 011705, 2013 | 61 | 2013 |
| Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? BS Sørensen, J Pawelke, J Bauer, NG Burnet, A Dasu, M Høyer, ... Radiotherapy and oncology 163, 177-184, 2021 | 57 | 2021 |
| The relationship between temporal variation of hypoxia, polarographic measurements and predictions of tumour response to radiation I Toma-Daşu, A Daşu, M Karlsson Physics in Medicine & Biology 49 (19), 4463, 2004 | 56 | 2004 |
| The effects of hypoxia on the theoretical modelling of tumour control probability A Daşu, I Toma-Daşu, M Karlsson Acta oncologica 44 (6), 563-571, 2005 | 52 | 2005 |
| Should single or distributed parameters be used to explain the steepness of tumour control probability curves? A Dasu, I Toma-Dasu, JF Fowler Physics in Medicine & Biology 48 (3), 387, 2003 | 49 | 2003 |
| Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment‐related toxicities following proton therapy for intracranial tumors J Ödén, I Toma‐Dasu, P Witt Nyström, E Traneus, A Dasu Medical physics 47 (2), 342-351, 2020 | 45 | 2020 |
| Modelling tumour oxygenation, reoxygenation and implications on treatment outcome I Toma-Dasu, A Dasu Computational and mathematical methods in medicine 2013 (1), 141087, 2013 | 45 | 2013 |
| Dose-effect models for risk–relationship to cell survival parameters A Daşu, I Toma-Daşu Acta oncologica 44 (8), 829-835, 2005 | 45 | 2005 |
